First-Ever Blood Collection Tube for cfDNA/cfRNA & gDNA/RNA Pairing Launched

LG Thin-Clients Feature Built-in RFID Capabilities Optimized for Use in Healthcare Facilities

Supporting its mission to help healthcare providers streamline operations and deliver exceptional patient care, LG Business Solutions USA introduced a new LG thin client...

Experien Group Acquired by Veranex

Veranex combines product development, regulatory, and market access expertise — globally and across complex and emerging markets.

The Synergy Tube is a BCT specifically designed to optimize nucleic acid recovery and cancer tumor cells (CTC) from the point of blood draw. The Synergy Tube and proprietary stabilizer dramatically improve the quantity and quality of these components for downstream genetic diagnostics.

The Synergy Tube is unbreakable yet has all of the characteristics of glass. cfDNA/cfRNA and cellular gDNA/RNA can be extracted from the same tube allowing you to pair results from the same sample. Draw volume is larger and with less hemolysis than any other product on the market. The Synergy Tube is designed to address the need to protect patient samples during transportation to the clinical lab.

SiO2 Materials Science, Chief Scientist, Dr Christopher Weikart, believes this breakthrough product has the ability to fundamentally change the future of the healthcare industry.

“The risk of bodily injury and pathogen exposure using fragile glass and the frustration of short draw volumes and sample contamination using permeable plastics are a thing of the past,” said Weikart.

Technical information can be found here.



Graham Belgrave Named to the 2021 PharmaVOICE 100 List of Distinguished Leaders

At Advanced Clinical, and from previous organizations, Belgrave serves as a mentor to several colleagues, where he challenges them to think outside of the box and take risks.

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.